29 results on '"Ignatius, Elisa H"'
Search Results
2. Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease
3. High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.
4. Pharmacological Considerations for Clinical Trials of Host-Directed Therapies for Tuberculosis
5. A validated liquid chromatography tandem mass spectrometry assay for the analysis of pretomanid in plasma samples from pulmonary tuberculosis patients
6. Efficacies of omadacycline + amikacin + imipenem and an alloral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease.
7. Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB
8. Pharmacological Considerations for Clinical Trials of Host-Directed Therapies for Tuberculosis
9. Getting to the point in point-of-care diagnostics for tuberculosis
10. Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease
11. Update on tuberculosis/HIV coinfections: across the spectrum from latent infection through drug-susceptible and drug-resistant disease
12. Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
13. Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results.
14. Nebulized Bacteriophage in a Patient With Refractory Mycobacterium abscessus Lung Disease
15. Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium aviumComplex Pulmonary Disease
16. A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial
17. A leap forward in assessing host-directed therapies for tuberculosis
18. Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity
19. Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis
20. Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis
21. PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia
22. Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
23. Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial
24. New Drugs for the Treatment of Tuberculosis
25. PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia.
26. Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis.
27. Reply to Decroo : High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis.
28. Pretomanid Pharmacokinetics in the Presence of Rifamycins: Interim Results from a Randomized Trial among Patients with Tuberculosis
29. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.